IOL CHEMICALS AND PHARMACEUTICALS
Quarterly Results Analysis [Mar2025]
IOL CHEMICALS AND PHARMACEUTICALS Quarterly Results
Consolidated | Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹528 Cr | ₹523 Cr | ₹526 Cr | ₹502 Cr | ₹504 Cr | ₹520 Cr | ₹545 Cr | ₹563 Cr |
Expenses | ₹465 Cr | ₹476 Cr | ₹484 Cr | ₹451 Cr | ₹454 Cr | ₹476 Cr | ₹481 Cr | ₹491 Cr |
Operating Income | ₹63 Cr | ₹47 Cr | ₹42 Cr | ₹51 Cr | ₹50 Cr | ₹44 Cr | ₹64 Cr | ₹73 Cr |
Other Income | ₹5 Cr | ₹4 Cr | ₹6 Cr | ₹7 Cr | ₹8 Cr | ₹8 Cr | ₹7 Cr | ₹7 Cr |
Interest | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹2 Cr | ₹3 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr |
Depreciation | ₹19 Cr | ₹19 Cr | ₹18 Cr | ₹17 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹14 Cr |
Profit Before Tax | ₹45 Cr | ₹28 Cr | ₹26 Cr | ₹40 Cr | ₹37 Cr | ₹32 Cr | ₹51 Cr | ₹61 Cr |
Profit After Tax | ₹31 Cr | ₹21 Cr | ₹19 Cr | ₹30 Cr | ₹28 Cr | ₹23 Cr | ₹38 Cr | ₹46 Cr |
EPS | ₹1.07 | ₹0.70 | ₹0.65 | ₹1.02 | ₹0.94 | ₹0.79 | ₹1.29 | ₹1.56 |
Industry Peers & Returns | 1W | 1M | 1Y |
IOL CHEMICALS AND PHARMACEUTICALS | -3.3% | -0.5% | 0.8% |
SUN PHARMACEUTICAL INDUSTRIES | -1.3% | -3.3% | 8.3% |
DIVIS LABORATORIES | -1.5% | 0.8% | 42.3% |
CIPLA | -1.7% | 2.3% | -5.8% |
TORRENT PHARMACEUTICALS | -3.3% | -1.4% | 9.8% |
DR REDDYS LABORATORIES | -1.6% | 8.4% | 10.6% |
MANKIND PHARMA | -3.3% | -6.1% | 3.4% |
ZYDUS LIFESCIENCES | -1.8% | 5.9% | -12% |
LUPIN | -3.2% | -1.1% | 22.1% |
IOL CHEMICALS AND PHARMACEUTICALS Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 0.86 % |
Y-o-Y | 4.73 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹528 Cr | 0.86 | |
Dec2024 | ₹523 Cr | -0.47 | |
Sep2024 | ₹526 Cr | 4.65 | |
Jun2024 | ₹502 Cr | -0.31 | |
Mar2024 | ₹504 Cr | -3.16 | |
Dec2023 | ₹520 Cr | -4.57 | |
Sep2023 | ₹545 Cr | -3.17 | |
Jun2023 | ₹563 Cr | - |
IOL CHEMICALS AND PHARMACEUTICALS Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 33.88 % |
Y-o-Y | 26.72 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹63 Cr | 33.88 | |
Dec2024 | ₹47 Cr | 12.75 | |
Sep2024 | ₹42 Cr | -18.67 | |
Jun2024 | ₹51 Cr | 3.21 | |
Mar2024 | ₹50 Cr | 11.66 | |
Dec2023 | ₹44 Cr | -30.92 | |
Sep2023 | ₹64 Cr | -11.47 | |
Jun2023 | ₹73 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 32.70 % |
Y-o-Y | 20.96 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 11.89% | 32.70 | |
Dec2024 | 8.96% | 13.27 | |
Sep2024 | 7.91% | -22.22 | |
Jun2024 | 10.17% | 3.46 | |
Mar2024 | 9.83% | 15.38 | |
Dec2023 | 8.52% | -27.61 | |
Sep2023 | 11.77% | -8.62 | |
Jun2023 | 12.88% | - |
IOL CHEMICALS AND PHARMACEUTICALS Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 53.04 % |
Y-o-Y | 13.76 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹31 Cr | 53.04 | |
Dec2024 | ₹21 Cr | 7.21 | |
Sep2024 | ₹19 Cr | -36.10 | |
Jun2024 | ₹30 Cr | 8.51 | |
Mar2024 | ₹28 Cr | 19.67 | |
Dec2023 | ₹23 Cr | -39.05 | |
Sep2023 | ₹38 Cr | -17.42 | |
Jun2023 | ₹46 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 51.79 % |
Y-o-Y | 8.58 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 5.95 % | 51.79 | |
Dec2024 | 3.92 % | 7.69 | |
Sep2024 | 3.64 % | -39.03 | |
Jun2024 | 5.97 % | 8.94 | |
Mar2024 | 5.48 % | 23.42 | |
Dec2023 | 4.44 % | -36.02 | |
Sep2023 | 6.94 % | -14.74 | |
Jun2023 | 8.14 % | - |
IOL CHEMICALS AND PHARMACEUTICALS Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 52.86 % |
Y-o-Y | 13.83 % |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹1.07 | 52.86 | |
Dec2024 | ₹0.7 | 7.69 | |
Sep2024 | ₹0.65 | -36.27 | |
Jun2024 | ₹1.02 | 8.51 | |
Mar2024 | ₹0.94 | 18.99 | |
Dec2023 | ₹0.79 | -38.76 | |
Sep2023 | ₹1.29 | -17.31 | |
Jun2023 | ₹1.56 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD